just saw Quince stock jumping hard in premarket - up nearly 57% which is wild. turns out they brought in LifeSci Capital to explore strategic alternatives, so basically they're looking at partnerships, acquisitions, maybe licensing deals. anything to boost shareholder value apparently. Quince hasn't been doing great tbh, trading between $0.12 and $4.55 over the past year. closed yesterday at $0.13 but jumped to $0.20 this morning. board said they won't give updates unless something concrete happens. could be nothing, could be something. either way the market's definitely betting on it right now. you guys holding biotech or staying away?

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin